Please provide your email address to receive an email when new articles are posted on . Interatrial shunt implant lowered HF hospitalization risk for patients with HFrEF vs. placebo. However, patients ...

LOS GATOS, Calif., Oct. 27, 2024 /PRNewswire/ -- Adona Medical, a Shifamed portfolio company that aims to deliver advanced solutions for heart failure, announced today the successful first-in-human ...

ATLANTA -- An interatrial shunt failed to provide a clinical benefit to people with heart failure (HF) overall in the RELIEVE-HF trial, though actual harm or benefit seemed to hinge on the patient's ...

A study of an investigational interatrial shunt for treating high-risk heart failure patients with reduced and preserved ejection fraction suggests the device has a high degree of safety and efficacy, ...

Shifamed portfolio company Adona Medical has raised $33.5m in a Series C financing round for supporting the next stage of product development and initiating clinical use of its interatrial shunt and ...

FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial. In its premarket approval application for the ...

ATLANTA, GA—The implantation of a Ventura (V-Wave) interatrial shunt failed to improve prognosis or reduce symptoms across a wide range of patients with heart failure (HF), results from a new ...

10 patients enrolled with 100% implantation success Adona's adjustable interatrial shunt is designed so it can be modified post-implantation to provide a more adaptive and personalized lifetime ...

The Interatrial shunt is intended for insignificantly obtrusive delivery to the heart using trans catheter systems. The dime-sized gadget is embedded into the septal wall between the atrial chambers, ...

CAESAREA, Israel--(BUSINESS WIRE)--V-Wave Ltd, maker of an investigational interatrial shunt device for patients with advanced heart failure (HF), announced today the results of its first human ...

Left-to-right atrial shunting is feasible, safe, and has potential beneficial effects in patients with heart failure, irrespective of their ejection fraction. These findings come from two studies ...